773092-05-0 - Factory, Suppliers, Manufacturers from China

773092-05-0, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Acotiamide Hydrochloride Trihydrate CAS 773092-05-0 API Manufacturer High Purity
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...

2022.12.28 09:07:45
2022.11.18 00:06:49
2022.08.02 01:11:33
2022.05.29 22:22:13
2021.12.17 01:53:31
2021.11.05 10:37:13

773092-05-0 - Factory, Suppliers, Manufacturers from China

Related Products

Acotiamide Hydrochloride Trihydrate CAS 773092-05-0 API Manufacturer High Purity

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

6-Cyanoindole CAS 15861-36-6 Purity >99.0% (HPLC) Factory High Quality

Polymyxin B Sulfate CAS 1405-20-5 Assay Microbiological ≥6500 IU/mg Factory

5-Nitroguaiacol CAS 636-93-1 (2-Methoxy-5-Nitrophenol) Purity >98.0% (HPLC)

Methylene Methanedisulfonate (MMDS) CAS 99591-74-9 Purity >99.0% Electrolyte Additive

Perphenazine CAS 58-39-9 Purity >99.5% (HPLC) High Quality

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Celecoxib CAS 169590-42-5 Assay 98.0~102.0%

H-Thr(tBu)-OtBu·AcOH CAS 5854-77-3 Purity >98.0% (HPLC) Factory

2-Bromotoluene CAS 95-46-5 Purity >99.8% (GC) Factory

tert-Butyl Acetate CAS 540-88-5 Purity >99.5% (GC) Factory High Quality

Luliconazole CAS 187164-19-8 Purity ≥99.0% HPLC Factory API High Quality

N-Methylphthalimide CAS 550-44-7 Purity >99.0% (GC) Factory

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

Method Of Analyzing Palladium Content In Palladium Catalysts

The “Summit on COVID-19 Diagnostics & Treatment”

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Xi presents award to top scientists

2022.12.28 09:07:45

2022.11.18 00:06:49

2022.08.02 01:11:33

2022.05.29 22:22:13

2021.12.17 01:53:31

2021.11.05 10:37:13

related search